tradingkey.logo

GE Healthcare Technologies Inc

GEHC
查看詳細走勢圖
78.386USD
-0.394-0.50%
交易中 美東報價延遲15分鐘
35.71B總市值
16.15本益比TTM

GE Healthcare Technologies Inc

78.386
-0.394-0.50%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.50%

5天

-4.28%

1月

-5.73%

6月

+0.86%

今年開始到現在

-4.43%

1年

-10.77%

查看詳細走勢圖

操作建議

GE Healthcare Technologies Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名47/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為92.07。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

GE Healthcare Technologies Inc評分

相關信息

行業排名
47 / 205
全市場排名
138 / 4540
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
極度看好

GE Healthcare Technologies Inc亮點

亮點風險
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
估值低估
公司最新PE估值16.23,處於3年歷史低位
肯·費雪持倉
明星投資者肯·費雪持倉,最新持倉4.55K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.10

分析師目標

基於 22 分析師
買入
評級
92.067
目標均價
+14.63%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

GE Healthcare Technologies Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

GE Healthcare Technologies Inc簡介

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
公司代碼GEHC
公司GE Healthcare Technologies Inc
CEOBankes (Jeannette)
網址https://www.gehealthcare.com
KeyAI